These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37810565)

  • 1. Retracted: Recurrence of Early Hepatocellular Carcinoma after Surgery May Be Related to Intestinal Oxidative Stress and the Development of a Predictive Model.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9790735. PubMed ID: 37810565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence of Early Hepatocellular Carcinoma after Surgery May Be Related to Intestinal Oxidative Stress and the Development of a Predictive Model.
    He Y; Liang T; Chen Z; Mo S; Liao Y; Gao Q; Huang K; Peng T; Zhou W; Han C
    Oxid Med Cell Longev; 2022; 2022():7261786. PubMed ID: 36238647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: The Relationship between Ultrasonographic Features of Hepatocellular Carcinoma and the Severity of Hepatocellular Carcinoma and the Expression of PTEN and Tg737.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9848563. PubMed ID: 37829384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: Development and Optimization of a Prognostic Model Associated with Stemness Genes in Hepatocellular Carcinoma.
    International BR
    Biomed Res Int; 2024; 2024():9815950. PubMed ID: 38230074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Preliminary Evaluation of Artificial Intelligence-Based Anti-Hepatocellular Carcinoma Molecular Target Study in Hepatocellular Carcinoma Diagnosis Research.
    International BR
    Biomed Res Int; 2023; 2023():9850584. PubMed ID: 37475788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments.
    International BR
    Biomed Res Int; 2023; 2023():9827803. PubMed ID: 37475816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Development of a Bile Acid-Related Gene Signature for Predicting Survival in Patients with Hepatocellular Carcinoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9865740. PubMed ID: 38094394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor.
    Oncology JO
    J Oncol; 2023; 2023():9803262. PubMed ID: 37869587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Analysis of Related Risk Factors of Microvascular Invasion in Hepatocellular Carcinoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9808276. PubMed ID: 37503372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9764352. PubMed ID: 37860436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Prognostic Value of Stem Cell Index-Related Characteristics in Primary Hepatocellular Carcinoma.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9850917. PubMed ID: 37502512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9764203. PubMed ID: 38094457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Cuproptosis-Related Genes CDK1 and COA6 Involved in the Prognosis Prediction of Liver Hepatocellular Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9786174. PubMed ID: 38077938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9809678. PubMed ID: 37538093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: Risk Factors for Brain Metastasis of Hepatocellular Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9783892. PubMed ID: 37772007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retracted] KIFC1 promotes the proliferation of hepatocellular carcinoma
    Wang X; Wang M; Li XY; Li J; Zhao DP
    Oncol Lett; 2023 Aug; 26(2):345. PubMed ID: 37427345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: microRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target.
    International BR
    Biomed Res Int; 2021; 2021():1916343. PubMed ID: 33728325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Systematic Analysis of Tumor Microenvironment Patterns and Oxidative Stress Characteristics of Endometrial Carcinoma Mediated by 5-Methylcytosine Regulators.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9825804. PubMed ID: 37810559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9853278. PubMed ID: 37266250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies.
    BioMed Research International
    Biomed Res Int; 2018; 2018():4560161. PubMed ID: 29854758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.